Your browser doesn't support javascript.
loading
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Grommes, Christian; Pastore, Alessandro; Palaskas, Nicolaos; Tang, Sarah S; Campos, Carl; Schartz, Derrek; Codega, Paolo; Nichol, Donna; Clark, Owen; Hsieh, Wan-Ying; Rohle, Dan; Rosenblum, Marc; Viale, Agnes; Tabar, Viviane S; Brennan, Cameron W; Gavrilovic, Igor T; Kaley, Thomas J; Nolan, Craig P; Omuro, Antonio; Pentsova, Elena; Thomas, Alissa A; Tsyvkin, Elina; Noy, Ariela; Palomba, M Lia; Hamlin, Paul; Sauter, Craig S; Moskowitz, Craig H; Wolfe, Julia; Dogan, Ahmet; Won, Minhee; Glass, Jon; Peak, Scott; Lallana, Enrico C; Hatzoglou, Vaios; Reiner, Anne S; Gutin, Philip H; Huse, Jason T; Panageas, Katherine S; Graeber, Thomas G; Schultz, Nikolaus; DeAngelis, Lisa M; Mellinghoff, Ingo K.
Afiliação
  • Grommes C; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Pastore A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Palaskas N; Department of Neurology, Weill Cornell Medical College, New York, New York.
  • Tang SS; Department of Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Campos C; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Schartz D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Codega P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nichol D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Clark O; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hsieh WY; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rohle D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rosenblum M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Viale A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tabar VS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Brennan CW; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gavrilovic IT; Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kaley TJ; Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nolan CP; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Omuro A; Department of Neurology, Weill Cornell Medical College, New York, New York.
  • Pentsova E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Thomas AA; Department of Neurology, Weill Cornell Medical College, New York, New York.
  • Tsyvkin E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Noy A; Department of Neurology, Weill Cornell Medical College, New York, New York.
  • Palomba ML; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hamlin P; Department of Neurology, Weill Cornell Medical College, New York, New York.
  • Sauter CS; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Moskowitz CH; Department of Neurology, Weill Cornell Medical College, New York, New York.
  • Wolfe J; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dogan A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Won M; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Glass J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Peak S; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Lallana EC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hatzoglou V; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Reiner AS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gutin PH; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Huse JT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Panageas KS; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Graeber TG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Schultz N; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • DeAngelis LM; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mellinghoff IK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Discov ; 7(9): 1018-1029, 2017 09.
Article em En | MEDLINE | ID: mdl-28619981
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Linfoma de Células B / Neoplasias do Sistema Nervoso Central / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Aged80 Idioma: En Revista: Cancer Discov Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Linfoma de Células B / Neoplasias do Sistema Nervoso Central / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Aged80 Idioma: En Revista: Cancer Discov Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos